Professional Documents
Culture Documents
Question Bank by DR Sushma Ghadigaonkar
Question Bank by DR Sushma Ghadigaonkar
Question Bank by DR Sushma Ghadigaonkar
Definitions
1. Pharmacology: a word derived from Pharmacon means drug and logos science. It is a
branch of science that deals with the study of drugs, sources, absorption, distribution,
metabolism, and excretion of drugs and physiochemical effects and mechanism of
action, sources, diagnosis, and prevention of drugs
2. Drug: it is the substance of physical, chemical, or biological origin used in the
prevention, treatment, and diagnosis of disease in man or animals.
3. WHO (1966): A drug is any substance or product that is used or intended to be used
to modify or explore physiological systems or pathological states for the benefit of
the recipient.
4. Prodrug: it is a drug that after the metabolic activation in the living body produces
therapeutic effects, where the parent drug molecule is ineffective or inert but its
metabolite is pharmacologically active.
5. Placebo: it is a Latin word meaning ‘I may please you’ . it refers to an
agent/substance/ preparation consisting of an inert pharmacological agent (dummy
drug) to simulate real drug therapy in exerting psychological impact of medication in
human subject
6. Dose: the amount of drug to be administered at one time which is necessary to elicit
the desired therapeutic response in patients and expressed as quantity per unit body
weight.
7. Doses: pleural of dose.
8. Dosage: it refers to determination and regulation of doses.
9. Materia medica : it is derived from a Latin word “ signifying medical material” it
treats about the name, source, distribution, physical and chemical characteristics,
action, doses, test of purity etc. Regarding drugs.
10. Comparative pharmacology: It is the study of relative effect of drug in different
species of animals.
11. Pharmacognosy: it is the study of source and identification of drugs of vegetable and
animal origin.
12. Posology : it is the study of medicine dosage, which varies with the species of
animals, intended effect of drugs and individual tolerance / susceptibility
13. Metrology: It is the study of weights and measures as applied to preparation and
administration of drugs.
14. Pharmacometrics: The study quantitative aspect of drug effects.
15. Pharmacy: it is the science and art of collection, preparation, standardization and
dispensing of drugs so as to make them fit for administration.
16. Official Pharmacy: Compounding and Dispensing drugs according to pharmacopoeia.
17. Extemporaneous pharmacy: compounding of prescriptions of a qualified
practitioners.
18. Pharmacoeconomics: it deals with quantification of therapeutic use of drugs in
relation to the cost of treatment. It helps at arriving at the economics of drug use and
the derived benefits.
19. Pharmacogenetics: it is the study of genetic influences on drug responses study of
genetically mediated variations in drug responses.
20. Pharmacogenomics: it is the study of prediction of drug responses between
individuals based on their genetic makeup.
21. Immunopharmacology: branch of pharmacology which deals with the study of drug
induced immunomodulation.
22. Molecular pharmacology: it is the study of chemical interaction between drug
molecule and chemical groups in cell in explaining the mechanism of drug action and
the effect observed. Drug molecules must react with biomolecules (receptors) in cells
in exerting their effects.
23. Pharmaco epidemiology: it is the study of drugs effect at population level in order to
identify the variation in drug response between individuals in a population and /or
groups of population
24. Experimental pharmacology: it is the study to determine the effect of drugs on
different systems of body and their mechanism using the laboratory animals.
25. Applied pharmacology: the study of relative effect of drugs in normal and diseased
animals.
26. Neuropharmacology: the branch of pharmacology which deals with the study of
actins and effects of drugs on nerve functions.
27. Vety. Clinical pharmacology: Clinical evaluation of a drug for use in animal by actual
observation and treatment of patient as distinguished from theoretical or experimental
study.
28. Chemotherapy: It is the branch of pharmacology dealing with drugs that selectively
inhibit or destroy specific agents of disease such as bacteria, virus, fungi and other
parasites also neoplastic disease.
29. Toxicology: the science that defines limits of safety of chemical agents to human and
animal population. Or the science dealing with study of poisons effect of therapeutic
agents in excess and substances having only toxic effects.
30. Pharmacotherapy: use of drugs in the treatment of diseases.
31. Pharmacokinetics: The study of absorption, distribution, metabolism and excretion of
drugs in body with respect to time. How the animal body affects the drugs.
32. Pharmacodynamics: How the drug affect the animal body. It is the study of
physiological and biochemical effects and mechanism of action of drugs. Action and
fate in body in the absence of disease.
33. Therapeutics: it describes the treatment of disease in general and includes use of
drugs, surgery, radiation, behavioral modifications and other modalities.
Rational: Nature of disease and action of drugs is well known.
Empirical: Both are unknown
Specific therapeutics / chemotherapy: Systemic infection / malignancy
General / accessory: treatment without drugs
Mechanical therapeutics: Massage, exercise. Pressure
Physical therapeutics: heat and air
Dietetic therapeutics: in obesity and diabetics
Psychotherapeutics: Advice and hypnotism
Hydrotherapy: water in treatment
Helitherapy : sunlight
Placebo:
34. Pharmacology : The science which deals with study of drugs with respect to its
source, properties (physical and chemical), actions on living system, fate in body,
effects (physiological and biochemical), uses in treatment of disease conditions and
toxicity.
35. Veterinary Pharmacology: it deals with the use of pharmacology knowledge in the
animal treatment.
36. Pharmacokinetics: is branch of pharmacology that deals with the study of absorption,
distribution, metabolism and excretion of drugs. The word pharmacokinetic is derived
from Greek word Pharmacon –drug, kinesis- movement meaning movement of drug
or It quantities fate of drugs in the body by the measurement of drug and its
metabolite conc. in blood and urine over period of time.
37. Absorption: process of movement of unchanged drug from its site of administration
to the blood stream.
38. Distribution: process by which drugs reversibly leave the blood stream and enter the
extravscular fluid and tissues.
39. Metabolism/Biotransformation: conversion from one chemical form of a substance to
another. Both Metabolism and Biotransformation terms are used interchangeably and
carry same meaning when applied to drug. Lipid, nonpolar drugs-water soluble.
40. Enzyme induction: several drugs or chemicals have the ability to increase drug
metabolizing activity of certain enzymes, interact with DNA –increase synthesis of
enzyme protein e.g. cytochrome P-450 and glucuronyl transferase. Reduce efficacy,
potency
41. Enzyme inhibition: several drugs or chemicals have the ability to decrease drug
metabolizing activity of certain enzymes, due to administration of hepatotoxic agents.
Results in depressed metabolism of drugs- enhanced plasma half life, duration of
action, efficacy.
42. Excretion: process by which drug and/or their metabolites are irreversibly transferred
from the body to external environment. Imp termination of drugs action.
43. Biliary excretion: route of drug removal in which drug and or metabolites are
excreted by haptocytes into the bile canaliculi and ultimately into duodenum via bile.
Digitoxin, Chloramphenicol.
44. Pulmonary excretion: gases and volatile substances are absorbed and excreted thro
lungs by simple diffusion nitrous oxide, alcohol
45. Mammary excretion: excretion of drug in milk, minor route of drug elimination, but
imp b’coz?
46. Salivary excretion: excretion of drug in saliva is lesser importance. Penicillin,
Phenytoin.
47. Gastro-intestinal excretion: excretion of drug in GI tract minor route, undergo
recycling (morphine)or excreted in feces.
48. Other: salicylic acid, alcohol, heavy metals-skin. Lachrymal fluid, intestinal fluid,
genital secretion. Heavy metals detected in hair and nails.
49. Minimum effective conc.(MEC): minimum conc. of drug in plasma required to
produce desirable pharmacological/ therapeutic response.
50. Maximum safe conc. or minimum toxic conc. :conc. of drug in plasma above which
toxic effects are produced.
51. Maximum plasma conc.: point of max conc. of drug in plasma.
52. Area under curve: total integrated area under plasma drug conc. time curve- express
total amt of drug that comes into systemic circulation after administration of drug.
53. Bioavailability: fraction or percentage of administered drug that reaches systemic
circulation in chemically unchanged form.
54. Area under curve: total integrated area under plasma drug conc. time curve from the
first time drug conc. can be measured to last time.
55. Volume of distribution: apparent volume of body fluid which would required to
contain total amount of drug in the body.
56. Half life: time taken for the conc. of drug in plasma to decline by one half or 50% of
initial value/ time required for body to eliminate half of the drug. Elimination half
life.
57. Peak effect:- maximal or peak pharmacological effect produced by the drug at peak
plasma conc.
58. Time of maximum conc.(tmax): time required for a drug to reach peak conc. in plasma-
faster absorption lower tmax. Useful in assessing efficacy of drugs used to treat acute
conditions-treated by single dose.
59. Onset of action: beginning of pharmacological response produced by drug, occurs
when plasma drug conc. Just exceeds the MEC.
60. Onset time: time required for drug to start producing pharmacological response,
usually corresponds to time fir plasma conc. to reach MEC after administration of
drugs.
61. Order of process: manner in which conc. of drug influences rate of process.
62. Zero order process: pharmacokinetic process whose rate is independent of conc. of
drug i.e. rate of pharmacokinetic process remain constant can’t increased further by
increasing conc.
63. First order process: pharmacokinetic process whose rate is whose rate is directly
proportional to conc. of drug i.e. greater conc. faster process.
64. Mixed order process: pharmacokinetic process whose rate is whose rate is mixture of
both zero order & first order processes. It follow zero at high conc. and first order at
low conc. of drug
65. volume of distribution is the theoretical volume that would have to be available for
drug to disperse in if the concentration everywhere in the body were the same as that
in the plasma or serum, the place where drug concentration sampling generally occurs
66. Dose rate: expression of dose in terms of amount of drug per unit body weight or
surface area.
67. Initial/loading dose: large dose of a drug given at the beginning of therapy to get
desired pharmacological response.
68. Maintenance dose: dose given during course of therapy to maintain desired
pharmacological effect produced by initial dose.
69. Divided dose: definite fraction of full dose given repeatedly at short interval so that
full dose is administered within specified period.
70. Lethal dose: dose of a chemical or drug that is likely to cause death.
71. Posology: study of determination of drug dosage of remedies.
72. Structure activity relationship: used to describe relationship between structure of drug
and its pharmacological activity.
73. Pharmacological effect: effect produced by pharmacological actions of a therapeutic
dose of a drug in the body.
74. Toxic/adverse effect: undesirable effect produced by a drug that is detrimental to
either survival or normal functioning of the animal
75. Side effect: undesirable effect produced by normal pharmacological actions of a drug
which may not be detrimental or harmful to the animal.
76. Transient effect: pharmacological effect produced by drug that remains for short
duration of time
77. Latent effect: pharmacological effect produced by a drug that has latent onset of
action.
78. Cumulative effect: progressive pharmacological effect produced by summation
incremental doses resulting from successive exposures of a drug.
79. Withdrawal effect: effect produced by abrupt discontinuance of a drug-additive drug
after long term treatment.
80. Risk benefit ratio: used to describe adverse effect of drug in relation to its beneficial
effect
81. Tachphylaxis:- rapid appearance of progressive decrease in tissue response following
repeated administration of a drug.
82. Tolerance: gradual decrease in responsiveness to a drug, taking days or weeks to
develop.
83. Drug resistance: loss of effectiveness of antimicrobial drugs.
84. Receptors: macromolecular components of cells or tissue to which drug interact/binds
and produced effects.
85. Drug action: it is initial combination of drug with receptors resulting in
conformational changes.
86. Drug effect: ultimate change in biological function brought about as consequence of
drug action.
87. Affinity: ability of the drug to combine with receptor (depends upon chemical
structure).
88. Intrinsic activity: ability of drug to evoke pharmacological response on combining
with receptor.
89. Agonist: drug that interacts with a specific receptor and elicits observable positive
response.
90. Antagonists: drug that interact with a specific receptor or other part of the effector
mechanism to inhibit action of agonist.
91. Drug receptor interaction: for a drug to be useful as a therapeutic agent it must not
only act selectively on receptor but should also be able to produce the desired extent
of pharmacological response.
92. Dose response relationship: relationship dose of a drug and magnitude of response
(effect).
93. Dose response curve: if dose response data plotted on a graph the curve obtained.
94. Threshold dose: minimal dose produces the desired observable pharmacological
response
95. Pharmacopoeia: drug compendium consisting of officially recognized drugs.
96. Full agonist: produce full effect on activation with receptors.
97. Partial agonist : compound has high affinity but low efficacy , have both agonist and
antagonist action can’t produce 100% response even 100% receptors r occupied , e.g.
pentazocine, Nalorpine.
98. Inverse agonist: when react with receptor produce opposite effect to those of
antagonist e.g. Benzodiazepines, B-carbolines.
99. Competitive antagonist: when there is competition between agonist and antagonist for
receptor to which both have affinity and capable of reversing or blocking agonist
effect. These have greater therapeutic value, e.g. Atropine, Propranolol,
Diphenhydramine
100. Noncompetitive antagonist :it prevent agonist from producing its effect by
irreversible interaction of antagonist with same site of agonist to combine with its
receptor is altered, e.g. Phenoxybenzamine, organosphosphorus pesticides
101. Pharmacological antagonism-: when drug reduces another drugs effect by binding to
same receptor. Competitive and non competitive antagonists are example of this
class.
102. Physiological antagonism: - when a drug reduces another drugs response due to
activation of second species of receptor by eliciting an opposing response e.g. on heart
atropine blocks acetylcholine effect by virtue of physiological antagonism.
103. Chemical antagonism: -when there is administration of second drug for the purpose of
changing the structure of first or modifying effect of first is known as chemical
antagonism e.g. chelators EDTA removes lead, antacid for gastric acidity
104. Physical antagonism: -adsorbent such as charcoal binds to the free form of
drug or poison in gut and remove them.
105. Pharmacokinetic antagonism: - when antagonist effectively reduces
concentration of active drug at its site of action e.g. phenobarbitone induce hepatic
microsomal enzyme.
106. Dose response relationship: mathematical description of relationship between dose
administered and response obtained by quantitative analysis of drug action.
107. Graded dose response relationship: Intensity of response increases with dose ,size of
response is measure in single biological unit
108. Threshold dose: minimum dose required to produce measurable response.
109. Ceiling dose: minimum dose produce maximal response or ceiling effect. Increase in
dose above ceiling level does not result in increase response.
110. Quantal dose response relationship: Quantal dose response curve are used to
determine the effective toxic, lethal, or any other fixed response and also gives proportion of
subject in population responding or not responding to effect of drug i.e. all or none / yes or
no dose response
111. Therapeutic index = Ehrlich introduced concept therapeutic index is the ratio of
median lethal dose and median effective dose i.e. LD50/ED50 or maximum tolerated dose
divided by curative dose, higher the ratio safer the drug e.g. Penicillin has high therapeutic
index and digitalis has low.
112. Therapeutic ratio= ratio of LD25 to ED75, is expressed by LD25/ED75, it given
better index of safety of drug. Dose effective in 99 animals out of 100.
113. Semi-synthetic drugs: Synthesized in lab utilizing naturally occurring complex
chemical as starting material. These are neither pure natural nor pure synthetic produced by
chemical alteration of natural origin drugs.
114. Synthesis – chemicals, organic chemicals, antibacterial substances, vegetable and
plant product whose chemical structure have either been synthesized semisynthesises in
laboratory under process of synthesis
115. drug interactions or drug-drug interaction :When two or more drugs are given
together or in quick succession, they may be either indifferent to each other or alter each
others response or When one drug interfere the action of other drug
116. Addition :When combined effect of two drugs is equal in magnitude to sum of the
effects of each drug given alone, interaction
117. The effect produced is called additive effect
118. Potentiation :When one drug having no effects if its own increases pharmacological
effect of another drug
119. Effect produced is called potentitive effect.
120. Synergism: When combined effect of two drugs is either greater in magnitude than
sum of the effects of each drugs given alone.
121. Effect produced is called synergistic effect
122. Maternal and fetal blood vessels separated by layer of trophoblastic cell that
constitutes placental barrier.
123. Conversion of active drug to inactive metabolites C/as inactivation/pharmacological
inactivation. Phenobaribitone-hydroxy, morphine.
124. Conversion of active drug to more active metabolites called bioactivation or
toxicological activation e.g. codeine- morphine , malathion-malaxon
125. Conversion of inactive drug to active metabolites c/as pharmacological activation e.g.
phenacetin-paracetamol, pivampicillin-ampicillin.
126. Conversion of active drug to equally active metabolites e.g. Digitoxin- digoxin
127. Conversion of active drug to active metabolites having different pharmacological
activity iproniazid (antidepressant)-isoniazid (antitubercular).
128. Bitters: increase the flow of gastric juice & appetite.
129. Stomachic Agents help in digestion by increasing gastric acid secretion & motility.
130. Drug development: design, synthesis & introduction of chemicals or other agents as
therapeutic agent i.e. drugs for treatment of disease in animals, man &birds.
131. Drug screening: study of chemicals or other substances in order to evaluate their
pharmacological activity-pharmacodynamic properties.
132. Simple screening- testing of chemicals or drug for one or two specific predetermined
pharmacological activity e.g. blood glucose level.
133. Programmed screening- screening of drug or agent or series of chemically related
compound as per pharmacological tests e.g. antihypertensive drugs for CVS, blood vessel,
heart rate, BP.
134. Blind screening- when there is prior pharmacological or chemical knowledge of
compound available then this procedure is adopted
135. Cardiotonics: drugs which specifically increase the force of contraction of a failing
heart by increasing the functional capacity of the cardiac muscles without a corresponding
increase in oxygen consumption of myocardium.
136. Cardiac stimulants: drugs which stimulate a failing heart exerting positive inotropic
as well as chronotropic action
137. Antiarrhythmic drugs: cardiac depressants used in the treatment of cardiac arrhythmia
(flutter and fibrillation)
138. Antihypertensive drugs: drugs used to reduce elevated blood pressure
139. Hematinics: drugs that promote hemoglobin synthesis and/or erythropoietin in
general used in the treatment of anemia
140. Blood coagulants: agents which promote blood clotting used for arresting
hemorrhages
141. Blood anticoagulants: drugs used to prevent the clotting of blood
142. Digitalization: procedure followed for administration of cardiac glycosides in the
treatment of CHF.
143. Coagulant: Agent used to control bleeding e. g. Adrenaline is used to control epitasis
144. Local or physiological coagulant: Control oozing of blood from minute vessels
145. Systemic haemostat: control oozing of blood from large vessels
146. Laxative –promote soft formed stool without griping and without loss of water
147. Purgatives-drugs which promote defecation.
148. Super Purgation-Over dose of purgative causes extreme and continued intestinal
activity due to that there is frequent and painful evacuation of fluid & blood stained feces
comes out.
149. Saline or osmotic purgatives :Agents which are not absorbed and retained in GIT and
exert their effect by holding considerable amt of water & increase intestinal bulk
150. Carminatives: Agents used to expel gases from stomach or intestine in treatment of
flatulence and colic.
151. Antidiarrhoeal: Agents which reduce the diarrhoea
152. Sodium bicarbonate is absorbed in systemic circulation & cause alkalosis hence it is
called systemic antacid.
153. Cholagogue : Agents promote flow of bile into the intestine – result contraction of
gall bladder
154. Cholaretics: Stimulate liver increase output of bile
155. hydrocholorectics Stimulate liver to increase output of bile of low specific gravity
156. Catharatics- Are the drugs that cause severe or drastic purgation
157. Antianaemic drugs or Hematinic drugs : Agents which stimulate production of blood
cells.
158. Ecbolics: Oxytocics /Uterotonics/myometrial stimulants. Helps expulsion of its
contents
159. Tocolytics :Uterine relaxant /uterine spasmolytics Agents retards uterine motility
Delay /postpone labour
160. Diuretics: substances which elicit Diuresis
161. Natriuretic effect (enhance secretion of sodium and thus water)
162. Expectorant - Agents which increases fluidity & volume of respiratory secretion &
result in productive cough and promote drainage during inflammatory conditions of
respiratory tracts.
163. Antitussive- Agents used to relief or suppress coughing. Also called as cough
sedatives.
164. Bronchodilators: Agents which relax smooth muscles of bronchi and cause dilatation
of respiratory passage.
165. Respiratory stimulants Agents helps in stimulation depressed respiration i.e.
associated with excess dose of anesthetics
166. Analeptics - stimulates respirations by direct action on respiratory centre. Stimulate
vasomotor centre.
167. Urinary antiseptics : Inhibit microbial growth inside the kidney, bladder and urinary
tract
168. Intravenous or Intravascular (IV)- placing a drug directly into the blood stream
(superficial veins)
169. Intramuscular (IM) - drug injected into layers of skeletal muscle
170. Subcutaneous - Absorption of drugs from the subcutaneous tissues under skin.
171. Intraperitoneal IP- peritoneal space
172. Intrathecal – intraspinal- subarachnoid spaces.
173. Epidural – deposited thro vertebral interspace into epidural space.
174. Intra-arterial –deposited into artery
175. Intracardiac- directly into heart muscle
176. Intratracheal – between rings of trachea
177. Intramedullary- bone marrow of bone
178. Intradermal – within layers of skin
179. Bath: bathing or immersion of body or any of its parts in medicated water of other
fluid medium.
180. Dip : type of bath – whole body is immersed for time in medicated fluid- insecticidal
fluid.
181. Inunction: application of semisolid or liquid prep on surface of body with smearing or
rubbing. Ointments, oils liniments.
182. Dusting: application of fine particles of solid materials on surface of body. Dusting
powder on skin for superficial skin conditions or in body cavities for surgical conditions.
183. Intraocular – ophthalmic drugs-local effects in the eye.
184. Intranasal: drugs solutions applied as sprays or nose drops.
185. Intramammary :Into orifice of teat with help of teat siphon
186. Transdermal delivery systems (TDS): topical application in form of adhesive patches
that deliver contained drug at predetermined & controlled rate in systemic circulation via
stratum corneum. Bypass first pass effect
187. Liposomes : lipid bodies Utilized for transportation of drugs to areas not normally
accessible to free form of drug
188. Emollients: These are inert , oily agents which soften ,smoothen ,lubricate and protect
the skin or mucous membrane against irritation
189. Demulcents: Inert substances used for soothening mucus membrane against the
irritation.
190. Astringents : Agents cause precipitation of proteins in the superficial layers of skin or
gastric mucosa
191. Antipruritics: Agent which prevent irritation or itching. Also c/as skin sedatives
192. GI mucosal protectants These are the agents which protect the intestinal mucosa
against irritation by forming a protective layer, neutralizing the irritants or adsorbing the
irritants.
193. Keratolytics: These are the agents which dissolve the inter cellular substances in the
Horney layer of the skin.
194. Caustics: These are the Agents which are corrosive cause local tissue destruction
sloughing.
195. Counter irritants: agents used to produce hyperemia in an attempt to relive pain and
promote healing of tissues beneath the skin, after application over the surface (skin).
196. Rubefacient- cause mild irritation & congestion in local area e.g. liniments of
camphor, ammonia and turpentine.
197. Vesicants – cause localized vesicles by severe irritation & damage to capillaries e.g.
red iodide of mercury ointment (10 & 7%).
198. Postulants –cause severe inflammation of deep seated cutaneous tissue & cause
pustules e.g. strong ointment of red iodide of mercury and canthardine ointment 12%.
199. Wound healers: These are the drugs capable of enhancing the process of wound
healing by preventing secondary bacterial infection through antiseptic action.
200. Chemical assay = Determine conc. of drug by chemical method – Spectrophotometer,
Flurometry, GLC, HPLC/mass spectroscopy.
201. Immunoassay = for assay of hormonal preparation
202. Bioassay = Estimation of quantity of biologically active agent in unit quantity of drug
(test drug) in comparison to response produced by standard or reference drug.
1. Galen
2. Valerious Cordus
3. F. W. A. Serturner
4. Priestly
5. Farady
Give reason:
1. Belladonna toxic to most species but not to rabbit – presence of atropinase enzyme.
2. Some drugs orally ineffective because they or antibiotic inactivated by ruminal flora
or they may fail to diffuse into GI tract.
3. Greyhounds more susceptible to thiobarbiturattes due to lean body weight provide
less fat for distribution.
4. Pigs highly susceptible to halothane induced malignant hyperpyrexia
5. Female more susceptible adverse effect of drugs than males.
6. Pregnancy cause marked hormonal & metabolic changes affect response of certain
drugs. E.g. oral anticoagulant toxic to pregnant animals. High progesterone level-
increase hepatic microsomal enzymes – increase drug metabolism
7. Very young & very old more susceptible to harmful effect of drug compared with
adult–under-developed & inefficient drug microsomal system while very old
reduced liver mass decreases hepatic blood flow microsomal enzyme activity.
8. Neonates lesser blood brain barrier result entrance of polar and water soluble drugs
in brain.
9. Lactation alters pharmacokinetic of certain drugs. Lactation enhances excretion of
some lipophillic drugs and toxicants in milk. E.g. DDT.
10. Metabolism & biotransformation used interchangeably when applied to drug-
product of both c/as metabolites.
11. Essential pharmacokinetic process: Lipid soluble & nonpolar comp- water soluble
and polar comp – excrete. If not convert –remain in body for long period- toxic
reactions. Plasma protein binding is Non-diffusible because it reduces efficiency of
drug distribution
12. Plasma protein binding is Pharmacologically inactive because it is heavy protein
bound drug- less efficiency – less potent
13. Do not undergo metabolism & excretion – thro glomerular filtration –long plasma
half life
14. Drug displacement interaction- administration of phenybutazone to patient on
warfarin therapy-If one drug binding to such site then administration of second
having affinity for same site result in displacement of first drug from binding site.
15. Restricted lipid insoluble drugs in high conc. Or for long period in maternal blood –
gain access to fetal by non carrier mediated process- ineffective as BBB.
16. Care should be taken during pregnancy –uncertainty of their harmful effects on
developing fetus
17. Repeated used of lubricant purgative may cause deficiency of vitamins A, D, &E
18. Generally do not give oral antacids within 1-2hr of other oral medication because of
their ability to decrease absorption of drug such as tetracycline, cimetidine,
ranitidine, digoxin, corticosteroid, & ketoconazole.
19. Magnesium containing antacids are contraindicated in animals with renal disease
because
20. Saline purgatives are contraindicated in dehydrated animals because -
21. Direct irritant purgatives causes -Dehydration and electrolytic imbalance
22. Direct irritant purgative contraindicated in pregnancy- tendency to cause smooth
muscle contraction Uterine contraction
23. Chronic use of Direct irritant purgative lead to intestinal mucosal damage
24. Tetracycline autacoids several milk foods and eggs – bind- precipitate iron
25. Levodopa thyroxin ciprofloxacin- chelates iron
26. Thyroxin caporal – complex formation iron
27. Ergot alkaloids contraindicated in During pregnancy and before 3 rd stage of labour .
28. Ergot alkaloids contraindicated in Liver and kidney disease.
29. Ergot alkaloid is Less used during parturition because sometimes it causes
spasmodic contraction and delays birth
30. Loop diuretic contraindicated in Anuria or patient sensitize to it
31. Loop diuretic contraindicated in Preexist electrolyte or water imbalance
32. Loop diuretic contraindicated in Impaired hepatic function
33. Loop diuretic with Aminoglycoside antibiotics- nephrotoxicity, Ototoxicity.
34. Loop diuretic with Purgatives – excessive fluid & electrolyte loss.
35. Loop diuretic with Cephalosporin's – kidney damage
36. Nitrofurantoin Hypersensitive patients
37. Nitrofurantoin Food producing animals – carcinogenic effect in lab animals
38. Nitrofurantoin parentally – systemic toxicity.
39. Methenamine : Renal insufficiency
40. Methenamine Liver disease – release ammonia is not detoxified
41. Methenamine Acidosis of renal disease - accumulate s in blood and produce acidosis
42. Methenamine Sod bicarbonate, Thiazide diuretic, carbonic anhydrous inhibitors,
citrates – inhibit antibacterial activity of Methenamine.
43. Methenamine Ascorbic acid, ammonium chloride , methionine enhance antibacterial
action.
44. Oral administration of drug is Suitable for GI tract infections and parasites
45. First-pass effect disadvantage of oral - drugs absorbed orally are initially transported
to the liver via the portal vein
46. Sometimes inefficient - only part of the drug may be absorbed
47. irritation to gastric mucosa - nausea and vomiting
48. destruction of drugs by gastric acid and digestive juices
49. effect too slow for emergencies
50. unpleasant taste of some drugs
51. unable to use in unconscious, uncooperative or vomiting patient
52. Oral administration is not useful in ruminants- large volume of ingesta decreases
absorption.
53. Poor administration – intratracheal delivery- aspiratory bronchopneumonia
54. Emetics are not used in ruminants
55. H2 antagonists exert antiulcer action.
56. Propranolol is used to treat ventricular fibrillation in dogs.
57. Magnesium salts act as saline purgative.
58. Diuretics are used along with cardiac glycosides in treating CHF.
59. Ruminants orally treated with broad spectrum antibiotics need vitamin B-complex
supplementation.
60. Synergism may be called as Pharmacological cooperation.
61. Drug conjugates are readily excretable.
62. Drug effects vary as chemical structure is altered.
63. Plasma protein binding of drug limits its concentration in tissue and
64. General anesthesia is not followed normally in adult ruminants.
65. Cocaine is regarded as mother of local anesthetics
66. Very old and very young animals do not metabolized the drugs effectively
67. Synergism is called Pharmacological co-operation.
68. Liquid dosage forms produce more rapid effects than solid dosage
69. Low and very high potency both can be dangerous
70. Biotransformation is essential process in pharmacokinetics
71. Higher therapeutic index , safer the drug
72. Plasma protein binding is a reversible interaction.
73. Acetylation is absent in dog
74. Glomurular infiltration is unidirectional process
75. Alteration of rate metabolism affect duration of drug action
76.
Choose the most appropriate words:-
1. The receptor concept was first introduced by …………………………
a. Langley c. Clark
b. WTN Paton d. Alexander Fleming
2. …………………. is used as dissociative anesthetics
a. Ketamine c. Xylazine
b. Morphine d. lignocaine
3. Nitrous oxide was discovered by ………………. in 1976
a. Faraday c. FWA Serturner
b. Priestly d. Alexander Fleming
4. An ultra short acting barbiturate used as intravenous anesthetics is …………………
a. Pentobarbitone c. phenobarbitone
b. Thiopentone d. Secobarbitone
5. A drug which produces calmness and reduces anxiety is a ………………………….
a. Sedative c. Tranquilizers
b. Hypnosis d. Narcotics
35.Denervation does not reduce the effect of indirectly acting sympathomimetics.- (F)
36.De polarising muscle relaxants will attach to MM. receptors and depolarize the post
junctional membrane.-(T)
37.Dogs are highly susceptible to Tubocurarine, a neuro muscular blocking agent.-(F)
38.Dopamine deficiency can be treated with L–Dopa.-(T)
39. d-isomer of curare is less active than l –isomer.- (F)
40.Histamine release is one of the important side effect of Tubocurarine.-(T)
41. l- isomer of tubocurarine is more active than d isomer.- (F)
42.Epinephrine is the most potent Beta receptor stimulant.-(F)
43.Ergot contain only three alkaloids.- (F)
44.Ergot is an alkaloid obtained from a fungus. -(F)
45.Ergot is obtained from rye plant.- (F)
46.Ergometrine mainly acts on Uterus.- (T)
47.Ergotoxin will comes under ergocristin group of alkaloids.-(F)
48.Generally Alpha receptors are excitatory in nature .-(T)
49.Gallamine is a synthetic short acting neuro muscular blocking agent.- (F)
50.Glycopyrrolate, a synthetic quarterinary ammonium compound is used as pre anesthetic
agent.-(T)
51.Hyoscine is a CNS suppressant at therapeutic dose-(T)
52.High dose of Nicotine initially stimulate parasympathetic and sympathetic ganglia and
then paralyse the neuro muscular junction.-(T)
53. l- isomer of noradrenaline is more powerful. -(T)
54.Isoproterenol is a synthetic catecholamine.-(T)
55.In most tissues α receptors are excitatory and β receptors are inhibitory in nature.-(T)
56.In Intestine α receptors are inhibitory and relaxation occurs.-(T)
57.In Heart muscle β receptors are excitatory in nature.-(T) 58.In synechia Physostigmine
must be used alternatively with Atropine. -(T)
59.Levo isomer of norepinephrine is more powerful .-(T)
60.L –Dopa can easily cross Blood Brain Barrier unlike Epinephrine. -(T)
61.M1 receptors mediate gastric secretion and relaxation of lower oesophageal Sphincter.-
(T)
62.M2 receptors predominate in myocardium and some smooth muscles.-(T)
63.M3 receptors are located in smooth muscles and secretary glands.- (T)
64.M4 receptors are not found in CNS.-(F)
65.Methocarbamol is a centrally acting muscle relaxant acts by preventing the release of
Acetyl choline at neuro muscular junction.-( F)
66.Methocarbamol preferentially block convulsion due to electric shock and strychnine.-(T)
67.Mephenesin is a neuromuscular blocker with very long duration of action.-(F)
68.Mephenesin carbamate is having less duration of muscle relaxant action than
Mephenesin.-(F)
69.Magnesium interfere with release of Acetyl choline from the nerve terminals.- (T)
70.Magnesium compete with Calcium for the transport mechanism for mobilization into
nerve terminals.-(T)
71.Most of the non catecholamine have direct and indirect action.-(T)
72.Muscarinic receptor subtypes of CNS is mainly M 1 and M 2.- (T)
73.Muscarinic receptor subtypes of Autonomic ganglia is mainly M 1.-(T)
74.Muscarinic receptor subtypes of end organ is mainly M 2 .-(T)
75.Neostigmine can counteract the effect of Suxamethonium.- (F)
76.Nor epinephrine is the most potent alpha receptor stimulant.- (F)
77.Nicotinic receptors are present in chromaphin cells.- ( T)
78.Nicotine can be absorbed even through the intact skin. -(T)
79.Nicotine first stimulate and then suppress both the sympathetic and parasympathetic
autonomic ganglia. -(T)
80.Nicotine will stimulate both acceleratory and inhibitory mechanism of heart.-(T)
81.Heart rate is reduced by nicotine even though acceleratory and inhibitory mechanisms are
stimulated.-(T)
82.Nicotinic receptor subtype NM are found in neuromuscular junction.- (T)
83.Nicotinic receptor subtype NN are found in the neurons of the CNS and autonomic
ganglia.-(T)
84.Norepinephrine is equally potent as Epinephrine on Beta 1 receptors.- (T)
85.Norepinephrine is slightly less potent on Alpha receptors.- (T)
86.Nor epinephrine is the most potent Alpha receptor stimulant.- (F)
87.Orciprenaline is metabolized by COMT.- (F)
88.Octa methyl pyrophosphoramide is a nerve gas synthesized by Americans in the second
world war.- (F)
89.Organo phosphates will inactivate only acetyl choline esterase in the body.-(F)
90.Organo phosphates will inactivate acetyl choline esterase as well as Pseudo cholinesterase
in the body.-(T)
91.Para sympathetic ganglia is not far from the organ being innervated.- (T)
92.Phentolamine and Tolazoline blocks both α 1 and 2 receptors .-(T)
93.Physostigmine is a parasympathomimetic alkaloid .-(T)
94.Physostigmine can be used to overcome curariform drugs. -(T)
95.Post synaptic α 2 receptors are seen in blood vessels, Thrombocytes and CNS.-(T)
96.Post junctional adrenergic receptor is α 2. -(F)
97.Prazosine blocks only α1 receptor and not α 2. -(T)
98.Presynaptic α 2 receptor stimulation inhibits the further release of transmitters.- (T)
99.Presynaptic α 2 receptors are found at adrenergic and cholinergic nerve terminals.- (T)
100.Prazosine is used in the treatment of congestive heart failure.-(T)
101.Propantheline is a synthetic quarterinary ammonium compound having antimuscarinic
action.- (T)
102.Propantheline is used as antispasmodic and antisecretary agent in diarrhea and colitis .-
(T)
103.Propantheline is an effective drug in urinary incontinence. -(T)
104.Pseudo ephedrine is having only less CNS effect. -(T)
105.Pseudo cholinesterase is seen in various body tissues.- (T)
106.Pseudo cholinesterase is mainly found in neuromuscular junction.-(F)
107.Sympathetic de-nervation can terminate the action of direct acting adrenergic Agent.- (F)
108.Sympathetic de-nervation can terminate the action of indirectly acting adrenergic Agent.-
(T)
109.Release of adrenaline causes distant vision.- (T)
110.Rectopamine increase lypolysis.- (T)
111.Streptomycin and Brevidil have additive action on muscle relaxation.- (T)
112.Saliva is increased by pilocarpine and decreased by Arecoline.-(F)
113.Small doses of Nicotine stimulate parasympathetic ganglia. -(T)
114.Small doses of Nicotine stimulate both acceleratory and inhibitory mechanism of Heart.-
(T)
115.Radial muscles of the eye carry α1 receptors and so mydriasis with adrenaline.- (T)
116.Sweat glands receive innervations only from parasympathetic system.- (F)
117.Suxamethonium is a Non depolarizing ultra-short acting muscle relaxant.-(F)
118.Since the therapeutic index of neuromuscular blocking agents are wide supervision by a
qualified person is not necessary for administration.- (F)
119.Succinyl choline is a competitive inhibitor of Acetyl choline.- (F)
120.The neurons of the preganglionic fibers are located in paravertebral ganglia.-(F)
121.The neurons of the post gang ionic fibers are located in CNS.- (F)
122.The pre ganglionic fibers of sympathetic system is shorter than the post ganglionic
fibers.-(T)
123.The proposed mechanism of action of Dantrolene is by depression of polysynaptic
pathway in internuncial spinal neuron.- (T)
124.The mediator of sweat glands in Horse is adrenaline.-(T)
125.The centre of autonomic nervous system is pituitary.-(F)
126.To reverse the effect of xylazine in ruminants Tolazoline is effective.-(T)
127.Tolazoline is a competitive antagonist for α 1 and 2 receptors.-(T)
128.Tyramine is an indirectly acting sympatho mimetic amine. -(T)
129.Terbutaline is an orally effective β2 agonist.- (T)
130.Terbutaline is not advisable orally in horse since the absorption is very low. -(T)
131.6-Hydroxy dopamine produce anatomical peripheral sympathectomy.-(T)
132.Yohimbine promote the formation of c AMP by blocking the α 2 receptors activation.-
(T)
133.Pseudo ephedrine have no relation to Ephedrine and have more action on CNS.-(F)
134.Beta cells of pancreas posses α 1 receptors.-(F)
135.Neostigmine is a parasympathomimetic alkaloid.-(F)
136.Glycopyrrolate is aquarterinary amines having more marked antisialagogue action than
Atropine—(T)
137.Active release of Nor epinephrine from granules is mimicked by Guanithidine and
blocked by Bretylium—(T)
138.Dopamine Beta hydroxylase is blocked by Disulfiram—(T)
139.MAO is inhibited by Pargylin and Tranylcypromide.—(T)
140.Tyramine induces Nor epinephrine release by displacing it from the cytoplasmic pool but
not from the granules.---(T)
141.Benzodiazepins can raise the threshold for CNS toxicity of anaesthetics –(T)
142.Scopolamine is not superior to atropine as an antisilagogue—(F)
143.Even though Scopolamine is having superior antisilagogue action than atropine it is not
recommended because of its more marked sedation—(T)
144.GABA A receptor causes an increase in chloride conductance—(T)
145.Benzodizepins act by enhancing pre and post synaptic inhibition through GABA.(T)
146.Picrotoxin antagonise Benzodiazepins in a non competitive manner.—(T)
147.Barbiturates prolong the GABA response rather than intensifying it as in the case of
Benzodiazepins.—(T)
148.The so called ―Sleeping sponge was used to induce loss of consciousness in ancient
age.—(T)
149.Dandrolene inhibit depolarisation triggered release of calcium ion from sarcoplasmic
reticulm—(T)
150.Diamine butyric acid is a competitive inhibitor of neuronal uptake of GABA--(T)
151.Nipecotic acid is a competitive inhibitor of GABA—(T)
152.The so called ― Sleeping sponge was produced by soaking sponge in extract of opium,
Hemlock, Hyoscyamus, Lettuce etc.—(T)
153.The major site of action of local anaesthetic is receptor operated ion channels.—(T)
154.The major site of action of local anaesthetic is not voltage depended ion channels.(T)
154.One of the metabolic product of Epinephrine and Norepinephrine is Vanilic mandelic
acid.—(T)
155.Sympathetic nervous system also contain small amount of Acetyl choline along with Nor
adrenaline.—(T)
156.Adrenaline relaxes non pregnant and pregnant uterus in rats.—(T)
157.Adrenaline constrict non pregnant and pregnant uterus in rabbits.—(T)
158.Adrenaline relaxes non pregnant uterus and constrict pregnant uterus in cats.—(T)
159.Adrenaline constrict pregnant uterus and relax non pregnant uterus in humans.—(T)
160.Adrenaline fecilitate gluconeogenesis.—(T)
161.Adrenaline causes phosphorylation of Troponin and combine with calcium in heart.—(T)
162.Pseudo ephedrine is having no action on bronchi.—(T)
163.Pseudo ephedrine is used mainly as a nasal decongestant .—(T)
164.Adrenal medulla of ferocious animal is having more nor- adrenaline than other
animals.(T)
165.If autonomic fibers to an organ is disconnected the organ will slowly atrophy.---(F)
166.Noortropics will facilitate learning.—(T)
167.L DOPA and 5HT enters the brain easily.—(T)
168.Progabid is a GABA analog.—(T) 169.Tyrosine hydroxylase is not a rate limiting
enzyme.—(F)